Enzon Pharmaceuticals

We are a biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and other life-threatening diseases. Our specialized sales force markets ABELCET®, ONCASPAR®, ADAGEN®, and DEPOCYT® in North America. In addition, we also receive royalties on sales of PEG-INTRON®, marketed by Schering-Plough Corporation, and MACUGEN®, marketed by OSI Pharmaceuticals and Pfizer Inc. Our product-driven strategy includes an extensive drug development program that leverages our proprietary technologies, including a next-generation PEGylation platform that utilizes linkers designed to release compounds at a controlled rate. Internal research and development efforts are complemented with strategic initiatives, such as partnerships designed to broaden our revenue base or provide access to promising new technologies or product development opportunities.

Contact Details: 685 Route 202/206 Bridgewater New Jersey 08807 United States of America Tel: (908)541-8600 Fax: (908)575-9457 Email: careers@enzon.com WWW: www.enzon.com/

Loading...

Recent Publications by Enzon Pharmaceuticals:
Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers. CPT-11, also known as irinotecan, is a prodrug that is approved for the...	29th July, 2008	Enzon Pharmaceuticals, Inc., 20 Kingsbridge Road, Piscataway, New Jersey	Bioconjug Chem. 2008 Apr;19(4):849-59. Epub 2008 Mar 28. DOI Direct Link
Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model. PURPOSE: Clinical development of SN38, the active metabolite of...	21st May, 2008	Enzon Pharmaceuticals, Inc., Piscataway, New Jersey 08854, USA.	Clin Cancer Res. 2008 Mar 15;14(6):1888-96. DOI Direct Link
Releasable PEGylation of proteins with customized linkers. Releasable PEGylation employs customized linkers that reversibly tether a...	6th May, 2008	Enzon Pharmaceuticals, Inc., 20 Kingsbridge Road, Piscataway, New Jersey	Adv Drug Deliv Rev. 2008 Jan 3;60(1):29-49. Epub 2007 Aug 16. DOI Direct Link
Releasable PEGylation of mesothelin targeted immunotoxin SS1P achieves single dosage complete regression of a human carcinoma in mice. Recombinant immunotoxins exhibit targeting and cytotoxic functions needed...	30th August, 2007	Enzon Pharmaceuticals, Incorporated, 20 Kingsbridge Road, Piscataway, New	Bioconjug Chem. 2007 May-Jun;18(3):773-84. Epub 2007 Mar 9. DOI Direct Link
Antibody engineering and modification technologies. Antibody engineering has become a well-developed discipline, encompassing...	27th July, 2007	Enzon Pharmaceuticals, Piscataway, NJ 08854-3969, USA.	Biomol Eng. 2007 Jun;24(2):201-15. Epub 2007 Mar 31. DOI Direct Link
→View more Enzon Pharmaceuticals research publications.

BioNews Results for Enzon Pharmaceuticals:
Enzon Pharmaceuticals exploring alternatives	Home News Tribune:  Aug 23 2008 8:18PM Matching: enzon pharmaceuticals
Lance Armstrong Foundation receives the CEO Cancer Gold Standard	Live Strong:  Aug 20 2008 7:34AM Matching: enzon pharmaceuticals
The Lance Armstrong Foundation Receives CEO Cancer Gold StandardTM Accreditation	FinanzNachrichten.de:  Aug 19 2008 8:37AM Matching: enzon pharmaceuticals
The Lance Armstrong Foundation Receives CEO Cancer Gold StandardTM Accreditation	Business Wire:  Aug 19 2008 8:13AM Matching: enzon pharmaceuticals
Enzon Pharmaceuticals Announces Intention to Explore Strategic Alternatives for Specialty Pharmaceuticals Busi	DiGiTAL50:  Aug 16 2008 12:54AM Matching: enzon pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution	→View more Enzon Pharmaceuticals news.

Enzon Pharmaceuticals Patents:
US Patent No.	Title
7413738	Releasable polymeric conjugates based on biodegradable linkers
6720306	Tetrapartate prodrugs
6764853	Method for targeted delivery of nucleic acids
6777387	Terminally-branched polymeric linkers containing extension moieties and polymeric conjugates containing the same
7033583	Polymeric thiol-linked prodrugs
→View more Enzon Pharmaceuticals patents.

Enzon Pharmaceuticals (ENZN) Financial information Links from Barchart
ENZN Quote from from Barchart.com
ENZN Chart from from Barchart.com
ENZN Profile from from Barchart.com
ENZN Opinion from from Barchart.com
→View more Enzon Pharmaceuticals finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 197 times since April 2007, the link to the organisation's website has been followed 25 times

Recent Search Terms used to find this page: enzon.com careers | antibody company in NJ | abelcet patent | PEGylation branched enzon | .

Search for more companies in Bridgewater

Search for more companies in New Jersey

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Enzon Pharmaceuticals